Get the Stockscreener App
36.14
3.08%
-1.15
After Hours:
36.14
Zai Lab Limited Adr stock is traded at $36.14, with a volume of 1.66M.
It is down -3.08% in the last 24 hours and up +4.33% over the past month.
See More
Previous Close:
$37.29
Open:
$35.48
24h Volume:
1.66M
Relative Volume:
2.11
Market Cap:
$3.86B
Revenue:
$355.75M
Net Income/Loss:
$-270.85M
P/E Ratio:
-13.39
EPS:
-2.7
Net Cash Flow:
$-218.63M
1W Performance:
+1.32%
1M Performance:
+4.33%
6M Performance:
+49.71%
1Y Performance:
+125.59%
1-Day Range:
$34.59
$36.92
1-Week Range:
$33.33
$39.77
52-Week Range:
$13.48
$39.77
Zai Lab Limited Adr Stock (ZLAB) Company Profile
Name
Zai Lab Limited Adr
Sector
Industry
Phone
862161632588
Address
4560 JINKE ROAD, SHANGHAI
Compare ZLAB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZLAB
Zai Lab Limited Adr
|
36.14 | 3.86B | 355.75M | -270.85M | -218.63M | -2.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Mar-03-25 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-14-23 | Initiated | Morgan Stanley | Overweight |
| Aug-10-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-21-22 | Initiated | Macquarie | Outperform |
| Oct-12-21 | Initiated | Bernstein | Mkt Perform |
| Apr-28-20 | Initiated | Goldman | Buy |
| Apr-15-20 | Initiated | Guggenheim | Buy |
| Jul-12-19 | Initiated | BofA/Merrill | Buy |
| Jul-05-19 | Initiated | Macquarie | Outperform |
| Jan-29-19 | Initiated | Credit Suisse | Outperform |
| Nov-21-18 | Initiated | Jefferies | Buy |
| Jun-21-18 | Resumed | Leerink Partners | Outperform |
| Feb-14-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-16-17 | Initiated | JP Morgan | Neutral |
| Oct-16-17 | Initiated | Leerink Partners | Outperform |
View All
Zai Lab Limited Adr Stock (ZLAB) Latest News
Altice USA Inc [ATUS] Shares Jump Approximately 12.30% Over the Year - Knox Daily
Institutional investors in Zai Lab Limited (NASDAQ:ZLAB) see US$441m decrease in market cap last week, although long-term gains have benefitted them. - Simply Wall St
Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting - BioSpace
US Bancorp DE Has $154,000 Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Is Zai Lab Limited (ZLAB) the Best Performing Growth Stock in 2025? - Insider Monkey
Zai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Patients with Recurrent or Metastatic Cervical Cancer - Yahoo Finance
Zai Lab (NASDAQ:ZLAB) Reaches New 12-Month High – Still a Buy? - Defense World
Brokers Set Expectations for Zai Lab FY2025 Earnings - Defense World
Insider Sell: Richard Gaynor Sells 2,500 Shares of Zai Lab Ltd (ZLAB) - GuruFocus.com
Wall Street Analysts Think Zai Lab Limited (ZLAB) Could Surge 64.42%: Read This Before Placing a Bet - MSN
Leerink Partnrs Forecasts Zai Lab FY2026 Earnings - Defense World
Zai Lab (NASDAQ:ZLAB) Receives “Neutral” Rating from Bank of America - Defense World
B of A Securities Downgrades Zai Lab LimitedDepositary Receipt () (ZLAB) - MSN
Zai Lab Announces Participation in Investor Conferences in March 2025 - Business Wire
Zai Lab Limited (NASDAQ:ZLAB) Q4 2024 Earnings Call Transcript - Insider Monkey
Zai Lab Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Updates - Yahoo Finance
Equities Analysts Set Expectations for Zai Lab Q1 Earnings - Armenian Reporter
Here's Why 'Trend' Investors Would Love Betting on Zai Lab Limited (ZLAB) - MSN
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MSN
Zai Lab Limited (ZLAB) Surges 9.0%: Is This an Indication of Further Gains? - Nasdaq
Q1 Earnings Forecast for Zai Lab Issued By Leerink Partnrs - Defense World
Financial Snapshot: Analyzing Zai Lab Limited ADR (ZLAB)’s Key Ratio Metrics - The Dwinnex
Principal Financial Group Inc. Invests $46.17 Million in Zai Lab Limited (NASDAQ:ZLAB) - Armenian Reporter
Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday - Benzinga
With 73% ownership in Zai Lab Limited (NASDAQ:ZLAB), institutional investors have a lot riding on the business - Yahoo Finance
Zai Lab Limited (NASDAQ:ZLAB) Short Interest Up 27.4% in January - Defense World
Sidley Advised Zai Lab on its Offering of ADSs and Issuance of Underlying Shares - Legal Desire News Network
Analysts Set Expectations for Zai Lab FY2024 Earnings - Defense World
Zai Lab (NASDAQ:ZLAB) Stock Rating Upgraded by Cantor Fitzgerald - Defense World
Forge Global Holdings Inc (FRGE)’s stock chart: A technical perspective - US Post News
Perimeter Solutions Inc (PRM)’s stock price in review: A technical analysis - US Post News
Was anything positive for Zai Lab Limited ADR (ZLAB) stock last session? - US Post News
United Natural Foods Inc (UNFI)’s stock performance: a year in review - US Post News
A stock that deserves closer examination: Cybin Inc (CYBN) - US Post News
Market Highlights: Zai Lab Limited ADR (ZLAB) Ends on a Low Note at 26.77 - The Dwinnex
Daily Progress: Concentrix Corp (CNXC) Drop -0.89, Closing at 48.99 - The Dwinnex
Market Watch: Rekor Systems Inc (REKR)’s Noteworthy Gain, Closing at 2.20 - The Dwinnex
Closing Strong: Selective Insurance Group Inc (SIGI) Ends at 83.49, Up 0.87 from Last Close - The Dwinnex
ZLAB (Zai Lab Limited ADR) may reap gains as insiders became active recently - Knox Daily
Zai Lab Limited ADR (ZLAB) looking to reclaim success with recent performance - SETE News
19,502 Shares in Zai Lab Limited (NASDAQ:ZLAB) Purchased by SG Americas Securities LLC - MarketBeat
SG Americas Securities LLC Makes New $511,000 Investment in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Wall Street Analysts Believe Zai Lab Limited (ZLAB) Could Rally 95.6%: Here's is How to Trade - Yahoo Finance
Zai Lab to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Recent Corporate Updates on February 27, 2025 - Business Wire
FDA gives Zai Lab’s small cell lung cancer therapeutic orphan drug designation - Mugglehead
Cantor Fitzgerald Comments on Zai Lab FY2025 Earnings - Defense World
Zai Lab Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the Treatment of Small Cell Lung Cancer (SCLC) - Yahoo Finance
Here’s Why Analysts Are Bullish on Zai Lab Limited (ZLAB) - Insider Monkey
Zai Lab Limited (NASDAQ:ZLAB) Position Decreased by JPMorgan Chase & Co. - Defense World
Schrodinger Inc (NASDAQ: SDGR) Up 1.66%: This Is What Analysts Are Now Forecasting - Stocks Register
Zai Lab Announces Acceptance of New Drug Application for KarXT for the Treatment of Schizophrenia - Business Wire
Zai Lab Limited Adr Stock (ZLAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.05%
1.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):